Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages.
about
Role of microglia in central nervous system infectionsExpression of excitatory amino acid transporter-1 in brain macrophages and microglia of HIV-infected patients. A neuroprotective role for activated microglia?Mitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infectionInterferon-α regulates glutaminase 1 promoter through STAT1 phosphorylation: relevance to HIV-1 associated neurocognitive disordersNitrated alpha-synuclein and microglial neuroregulatory activities.Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.Proteomic analysis of HIV-infected macrophagesMethamphetamine abuse, HIV infection, and neurotoxicity.Retrograde and anterograde transport of HIV protein gp120 in the nervous system.Involvement of the 4-aminopyridine-sensitive transient A-type K+ current in macrophage-induced neuronal injury.Glutamate metabolism and HIV-associated neurocognitive disorders.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Heme oxygenase-1 dysregulation in the brain: implications for HIV-associated neurocognitive disorders.Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia.Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disordersA multifunctional cytoprotective agent that reduces neurodegeneration after ischemia.Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection.HIV neurotoxicity: potential therapeutic interventionsParallel high throughput neuronal toxicity assays demonstrate uncoupling between loss of mitochondrial membrane potential and neuronal damage in a model of HIV-induced neurodegenerationSTAT1 regulates human glutaminase 1 promoter activity through multiple binding sites in HIV-1 infected macrophagesHIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanismDimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotectionPotentiation of Excitotoxicity in HIV-1 Associated Dementia and the Significance of Glutaminase.Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminaseHIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders.Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral TherapyHIV-1 infection and AIDS: consequences for the central nervous system.HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity.Glutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: relevant to HIV-1-associated neurocognitive disorders.Glutaminase-containing microvesicles from HIV-1-infected macrophages and immune-activated microglia induce neurotoxicity.PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell GrowthDifferential effects of HIV infected macrophages on dorsal root ganglia neurons and axonsNeuroinflammation in treated HIV-positive individuals: A TSPO PET study.Peripheral blood HIV DNA is associated with atrophy of cerebellar and subcortical gray matter.HIV-infected macrophages mediate neuronal apoptosis through mitochondrial glutaminaseEnhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology.IL-1β and TNF-α induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase.Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage.
P2860
Q24563024-EAD10F7C-B372-41A5-9425-CCB6EAFF1B2BQ28206867-4ABE62C5-8E34-4365-85FC-768AEC7D1A75Q28396045-72ACAD00-2BCA-48EF-9668-EE2AA1C00B2DQ28482001-86A10F5D-4625-4B82-8C35-28C5A3B50E52Q33315262-4BF7B8CE-410B-44D6-966C-D22861F29AC8Q33726019-39477E30-670F-44F8-AA3D-886DDDF4485FQ33770687-99D7903B-6C30-44C6-8FE5-947F987F203BQ33799373-8300066F-AB0E-4330-ACDE-CF9D2206FBA3Q33802715-B28948DF-3734-444B-86D1-F9F4A3536D5EQ33807609-FBE9961C-3B61-47C1-B4BD-E5235C97E486Q33903612-6CCEEEA0-1674-491F-9EF1-3290CF0C1BDDQ34037622-59EDB981-7958-46C2-8E9C-019E5873D834Q34139883-EC1B7908-543D-4979-BF95-69DC4976448CQ34162648-D2C0A4CA-369E-4E76-B451-CAB99CF1F29FQ34302241-67FDEE7B-1270-4743-863F-455A66B9A742Q34311736-19DEA916-0766-4CE6-A053-293FBC9B05BFQ34335109-3FB88EB6-E299-4D2D-AF5E-B2EF84F366E9Q34508049-ED105AD5-09CB-48D1-9441-99D808DC0F60Q34795283-16FECDE4-5600-404C-81E1-BF15A464498FQ34970388-F8092B83-1498-4F80-BEB1-11D6315C691DQ35006405-0DB5134E-F071-4BE0-A581-7AA8561F39D0Q35007551-F9E5F9BB-5A49-4877-AEF6-31B31D09E21CQ35522971-EA439DCD-6600-4A80-95EC-7B431C942C1BQ35699016-71685316-908B-4225-A2D6-C956110449CAQ35990460-C03CA027-1BD5-453D-90FC-9C759AD54667Q36010129-B566A3F5-923C-4AA2-B014-0AE40795BD4AQ36086223-C0D7489B-F7A3-4B31-ACCA-EEDD7F9ADF58Q36098879-7396295D-DB97-4323-89ED-375B1E1E8F21Q36124813-024DFC6C-9527-45E6-AD74-799A0DFA9A06Q36124818-EF7A948E-E892-4329-83BA-5145C283B36FQ36256681-C90B3F1B-B0F8-405D-937A-CE1541433C17Q36310404-849FB8CD-0F1F-43C8-92DE-0D8BB517FE16Q36501938-389D8ECA-84E1-4EC8-ADAF-7D6D6B23EBB7Q36796466-33334FA9-47DE-4B1F-A868-A247F554FCABQ37035634-AF555116-39B9-4B07-988B-F11B8F20D45CQ37038443-0FBDE2A8-DC99-4AE0-A9D1-15FEE16AD784Q37086459-97328F2F-1B69-4212-B9CF-70455367EBADQ37106108-FB550A7A-3D78-4073-8FD5-441F01290032Q37122279-888DD75E-E474-4267-B2CB-3DA9CADB0DD7Q37158121-352C0B3E-DE7F-43DF-87FE-9D96AFCB92A6
P2860
Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Glutamate is a mediator of neu ...... ed HIV-1-infected macrophages.
@en
Glutamate is a mediator of neu ...... ed HIV-1-infected macrophages.
@nl
type
label
Glutamate is a mediator of neu ...... ed HIV-1-infected macrophages.
@en
Glutamate is a mediator of neu ...... ed HIV-1-infected macrophages.
@nl
prefLabel
Glutamate is a mediator of neu ...... ed HIV-1-infected macrophages.
@en
Glutamate is a mediator of neu ...... ed HIV-1-infected macrophages.
@nl
P2093
P1476
Glutamate is a mediator of neu ...... ed HIV-1-infected macrophages.
@en
P2093
Gendelman HE
P304
P356
10.1016/S0165-5728(01)00315-0
P577
2001-07-01T00:00:00Z